{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:39:20Z","timestamp":1792442360948,"version":"4.5.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"\n Importance<\/jats:title>\n The use of valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) has been rapidly expanding as an alternative treatment to redo surgical aortic valve replacement (SAVR) for failed bioprosthetic valves despite limited long-term data.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess mortality and morbidity in patients undergoing intervention for failed bioprosthetic SAVR.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a retrospective population-based cohort analysis conducted between January 1, 2015, and December 31, 2020, with a median (IQR) follow-up time of 2.3 (1.1-4.0) years. A total of 1771 patients with a history of bioprosthetic SAVR who underwent ViV-TAVR or redo SAVR in California, New York, and New Jersey were included. Data were obtained from the California Department of Health Care Access and Information, the New York Statewide Planning and Research Cooperative System, and the New Jersey Discharge Data Collection System. Exclusion criteria included undergoing TAVR or redo SAVR within 5 years from initial SAVR, as well as infective endocarditis, concomitant surgical procedures, and out-of-state residency. Propensity matching yielded 375 patient pairs. Data were analyzed from January to December 2023.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n ViV-TAVR vs redo SAVR.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measurements<\/jats:title>\n The primary outcome was all-cause mortality. Secondary outcomes were stroke, heart failure hospitalization, reoperation, major bleeding, acute kidney failure, new pacemaker insertion, and infective endocarditis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n From 2015 through 2020, the proportion of patients undergoing ViV-TAVR vs redo SAVR increased from 159 of 451 (35.3%) to 498 or 797 (62.5%). Of 1771 participants, 653 (36.9%) were female, and the mean (SD) age was 74.4 (11.3) years. Periprocedural mortality and stroke rates were similar between propensity-matched groups. The ViV-TAVR group had lower periprocedural rates of major bleeding (2.4% vs 5.1%;\n P<\/jats:italic>\n \u2009=\u2009.05), acute kidney failure (1.3% vs 7.2%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and new pacemaker implantations (3.5% vs 10.9%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The 5-year all-cause mortality rate was 23.4% (95% CI, 15.7-34.1) in the ViV-TAVR group and 13.3% (95% CI, 9.2-18.9) in the redo SAVR group. In a landmark analysis, no difference in mortality was observed up to 2 years (hazard ratio, 1.03; 95% CI, 0.59-1.78), but after 2 years, ViV-TAVR was associated with higher mortality (hazard ratio, 2.97; 95% CI, 1.18-7.47) as well as with a higher incidence of heart failure hospitalization (hazard ratio, 3.81; 95% CI, 1.57-9.22). There were no differences in 5-year incidence of stroke, reoperation, major bleeding, or infective endocarditis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Compared with redo SAVR, ViV-TAVR was associated with a lower incidence of periprocedural complications and a similar incidence of all-cause mortality through 2 years\u2019 follow-up. However, ViV-TAVR was associated with higher rates of late mortality and heart failure hospitalization. These findings may be influenced by residual confounding and require adjudication in a randomized clinical trial.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2024.1049","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:33:08Z","timestamp":1716377588000},"page":"631","source":"Crossref","is-referenced-by-count":40,"title":["Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves"],"prefix":"10.1001","volume":"9","author":[{"given":"Jessica H.","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Itagaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"O\u2019Gara","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[{"name":"Cardiac and Thoracic Surgery, Baylor Scott & White Health, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marc","family":"Gillinov","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"El-Hamamsy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert H. L.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Bagiella","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Moskowitz","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annetine C.","family":"Gelijns","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Borger","sequence":"additional","affiliation":[{"name":"Leipzig Heart Center, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia N.","family":"Egorova","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"13","key":"hoi240022r1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.2014.12679","article-title":"Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.","volume":"312","author":"Chiang","year":"2014","journal-title":"JAMA"},{"issue":"34","key":"hoi240022r2","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1093\/eurheartj\/ehv580","article-title":"Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.","volume":"37","author":"Glaser","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"hoi240022r3","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement.","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"hoi240022r4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.athoracsur.2015.04.062","article-title":"Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures.","volume":"100","author":"Kaneko","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"21","key":"hoi240022r5","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.115.015939","article-title":"Characteristics and outcomes of patients with severe bioprosthetic aortic valve stenosis undergoing redo surgical aortic valve replacement.","volume":"132","author":"Naji","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"hoi240022r6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.","volume":"312","author":"Dvir","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"hoi240022r7","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement.","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"hoi240022r8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"hoi240022r9","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"29","key":"hoi240022r10","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/eurheartj\/ehaa544","article-title":"Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.","volume":"41","author":"Bleiziffer","year":"2020","journal-title":"Eur Heart J"},{"issue":"10","key":"hoi240022r11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008155","article-title":"Durability and clinical outcomes of transcatheter aortic valve replacement for failed surgical bioprostheses.","volume":"12","author":"Dauerman","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"hoi240022r12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jcin.2022.02.014","article-title":"5-Year follow-up from the PARTNER 2 Aortic Valve-In-Valve Registry for Degenerated Aortic Surgical Bioprostheses.","volume":"15","author":"Hahn","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"hoi240022r13","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"hoi240022r14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"hoi240022r15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.athoracsur.2019.03.084","article-title":"Transcatheter valve-in-valve vs surgical replacement of failing stented aortic biological valves.","volume":"108","author":"Sedeek","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"hoi240022r16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jacc.2018.04.074","article-title":"Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: the STS\/ACC registry.","volume":"72","author":"Tuzcu","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"29","key":"hoi240022r17","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/eurheartj\/ehaa252","article-title":"Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.","volume":"41","author":"Hirji","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"hoi240022r18","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.amjcard.2020.02.005","article-title":"Valve-in-valve transcatheter implantation versus redo surgical aortic valve replacement.","volume":"125","author":"Malik","year":"2020","journal-title":"Am J Cardiol"},{"issue":"5","key":"hoi240022r19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jacc.2020.06.010","article-title":"Transcatheter valve-in-valve aortic valve replacement as an alternative to surgical re-replacement.","volume":"76","author":"Deharo","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi240022r20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jcin.2019.10.030","article-title":"Transcatheter ViV versus redo surgical avr for the management of failed biological prosthesis: early and late outcomes in a propensity-matched cohort.","volume":"13","author":"Tam","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"hoi240022r21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022150","article-title":"Identification of frailty using a claims-based frailty index in the CoreValve studies: findings from the EXTEND-FRAILTY study.","volume":"10","author":"Strom","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"hoi240022r22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies.","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"hoi240022r23","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.jacc.2019.08.1034","article-title":"Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week.","volume":"74","author":"Gregson","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hoi240022r24","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial.","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"hoi240022r25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement.","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"issue":"30","key":"hoi240022r26","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.","volume":"42","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"hoi240022r27","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamacardio.2022.2695","article-title":"Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial.","volume":"7","author":"Van Mieghem","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"5","key":"hoi240022r28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ccd.v70:5","article-title":"Transcatheter valve in valve implants for failed prosthetic valves.","volume":"70","author":"Webb","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"hoi240022r29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ccd.v70:5","article-title":"Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system.","volume":"70","author":"Wenaweser","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"hoi240022r30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/heartjnl-2017-312422","article-title":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve.","volume":"104","author":"Bleiziffer","year":"2018","journal-title":"Heart"},{"issue":"22","key":"hoi240022r31","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.jacc.2018.09.001","article-title":"Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS\/ACC TVT Registry.","volume":"72","author":"Herrmann","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hoi240022r32","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1093\/eurheartj\/ehs003","article-title":"The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27?186 patients with 133?141 patient-years.","volume":"33","author":"Head","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi240022r33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.athoracsur.2018.01.090","article-title":"The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement.","volume":"106","author":"Fallon","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"hoi240022r34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2022.11.013","article-title":"Balloon expandable vs. self expanding transcatheter valve for degenerated bioprosthesis: design and rationale of the BASELINE trial.","volume":"256","author":"Nuis","year":"2023","journal-title":"Am Heart J"},{"issue":"7","key":"hoi240022r35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jacc.2022.05.005","article-title":"Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses.","volume":"80","author":"Rod\u00e9s-Cabau","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi240022r36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamacardio.2022.4627","article-title":"Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk.","volume":"8","author":"O\u2019Hair","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2819144\/jamacardiology_tran_2024_oi_240022_1719329876.33303.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:06:03Z","timestamp":1720609563000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2819144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.1049","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}